Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Versus Vaginal Misoprostol in Missed Abortion
NCT07526064Phase 1Not yet recruiting
- Start
- May 2026
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of misoprostol in missed abortion (2 arms). Primary endpoints: Induction to Expulsion Interval at 48 hours and Efficacy of Oral Versus Vaginal route at 24 hours. Planned start May 2026; status: not yet recruiting.
02
Drugs
misoprostol
03
Conditions
missed abortion
Beyond the preview
Go deeper on NCT07526064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07526064.